Valuation: PharmaEssentia Corporation

Market Cap 479B 15.03B 13.22B 12.46B 11.37B 21.27B 1,443B 21.43B 150B 57.96B 734B 56.44B 55.21B 2,390B P/E 2026 *
43.6x
P/E 2027 * 27.4x
Enterprise Value 452B 14.2B 12.49B 11.77B 10.74B 20.09B 1,363B 20.25B 141B 54.75B 694B 53.31B 52.16B 2,257B EV / Sales 2026 *
16x
EV / Sales 2027 * 11.1x
Free-Float
77.94%
Yield 2026 *
0.35%
Yield 2027 * 0.2%
1 day-1.70%
1 week-4.15%
Current month-17.20%
1 month-17.50%
3 months+17.01%
6 months+108.67%
Current year+172.60%
1 week 1,125
Extreme 1125
1,215
1 month 1,125
Extreme 1125
1,645
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 56.05
Extreme 56.051993
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 2016-12-31
Director of Finance/CFO - 2015-10-13
President - 2015-06-24
Director TitleAgeSince
Director/Board Member - 2000-05-08
Chairman - 2012-09-23
Director/Board Member - 2015-05-28
Change 5-day change 1-year change 3-year change Capi.($)
-1.70%-4.15%+147.82%+325.69% 15.32B
-3.30%+2.97%+54.99%+104.15% 74.18B
-0.12%-1.63%+33.14%+74.86% 59.55B
+2.71%-0.84%-16.39%+364.46% 25.84B
+0.81%+3.58%+1.01%-5.14% 24.73B
-1.05%+2.58%+24.27%-10.32% 20.87B
+2.15%+2.06%+45.57%+169.79% 14.06B
-0.43%-5.32%-14.46%+775.94% 13.12B
+0.04%-3.00%+15.76%+234.69% 11.85B
-1.33%+0.43%+103.29%+142.55% 9.46B
Average -0.22%-0.54%+39.50%+217.67% 26.9B
Weighted average by Cap. -0.73%-0.15%+37.32%+159.67%

Financials

2026 *2027 *
Net sales 28.33B 890M 783M 738M 673M 1.26B 85.4B 1.27B 8.85B 3.43B 43.46B 3.34B 3.27B 141B 40.06B 1.26B 1.11B 1.04B 952M 1.78B 121B 1.79B 12.52B 4.85B 61.46B 4.72B 4.62B 200B
Net income 11.02B 346M 304M 287M 262M 490M 33.23B 494M 3.44B 1.33B 16.91B 1.3B 1.27B 55.03B 17.69B 556M 489M 461M 420M 786M 53.33B 792M 5.53B 2.14B 27.14B 2.09B 2.04B 88.32B
Net Debt -26.52B -833M -733M -691M -630M -1.18B -79.96B -1.19B -8.29B -3.21B -40.69B -3.13B -3.06B -132B -34.73B -1.09B -959M -904M -825M -1.54B -105B -1.55B -10.85B -4.21B -53.28B -4.09B -4.01B -173B
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
26-09-23 NT$1,155.00 -1.70% 1,460,375
26-09-23 NT$1,175.00 +1.29% 2,241,457
26-09-22 NT$1,160.00 +0.87% 3,254,526
26-09-21 NT$1,150.00 -2.54% 2,811,409
26-09-18 NT$1,180.00 -1.26% 12,720,966
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,155.00TWD
Average target price
1,397.26TWD
Spread / Average Target
+20.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock